Skip to content

Utah Medical Products UTMD Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
PDE
Pro-Dex, Inc.PDEX
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
UFP Technologies logo
UFP TechnologiesUFPT
InfuSystem Holdings logo
InfuSystem HoldingsINFU
ICU Medical logo
ICU MedicalICUI

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's common stock, shares, outstanding?
Utah Medical Products (UTMD) reported common stock, shares, outstanding of $3.18M in Q1 2026.
How has Utah Medical Products's common stock, shares, outstanding changed year-over-year?
Utah Medical Products's common stock, shares, outstanding decreased by 3.0% year-over-year, from $3.28M to $3.18M.
What is the long-term trend for Utah Medical Products's common stock, shares, outstanding?
Over 5 years (2020 to 2025), Utah Medical Products's common stock, shares, outstanding has grown at a -2.6% compound annual growth rate (CAGR), from $3.64M to $3.19M.